The GLP-1 space looked very different twelve months ago. Then came a wave of regulatory warning letters, a high-profile legal settlement between Novo Nordisk and several telehealth companies, and the looming arrival of oral options like orforglipron. By mid-2026, a dozen brands had quietly changed what they offer, who writes the prescriptions, and whether compounded options are even on the table. If you started a program in 2024 or early 2025, the company you signed up with may be running a completely different model now. This list ranks ten providers by the quality of their GLP-1 ongoing support, not just their intake process.
1. FormBlends
FormBlends earns the top spot because it solves two problems at once that nobody else in this category consistently solves together: it keeps compounded GLP-1 options available through a licensed pharmacy operating under 503A standards, and it wraps a full peptide catalog around those GLP-1 programs under the same clinical roof. Most weight-loss telehealth companies offer GLP-1s only. Most peptide sellers operate in a research-only gray zone with no prescriber involved. FormBlends sits at neither extreme.
The intake is online. A physician reviews your case and, if appropriate, signs off. The compounding pharmacy itself holds FDA inspection status. Shipments include cold-chain packaging and go out to 47 states at no additional charge.
What separates the ongoing experience is transparency on two fronts. First, every batch of compounded semaglutide goes through HPLC purity testing, and the result for semaglutide is published at 99.1 percent. You can see that number before you order, not buried in a request-only document. Second, pricing is flat and visible without a membership fee layered on top. You see the per-vial cost before you enter a credit card number. That is genuinely uncommon in this space.
One honest caveat: compounded medications are not the same as FDA-approved drug products. The pharmacy meets federal manufacturing standards, but meeting those standards is a different bar than clearing the full FDA approval process. Anyone using peptides beyond the GLP-1s should also know that human clinical evidence for most of those compounds remains limited to early-stage or animal research.

2. Mochi Health
Mochi uses board-certified obesity-medicine specialists rather than general-practice telehealth clinicians. That distinction matters at the 6-month mark, when dosing adjustments and plateau conversations require someone who actually specializes in metabolic health. Compounded semaglutide runs about $99 per month and compounded tirzepatide around $199, with meaningful discounts on 3- and 12-month commitments. Insurance navigation for branded options is also available.
3. Ro Body
Ro has built a prior-authorization team into its membership structure, which is more useful than it sounds. Getting branded GLP-1s covered by insurance without that help can take weeks. Membership starts around $39 for the first month, then roughly $74 per month on an annual plan or $149 month-to-month, with medication billed separately. The app is polished and the onboarding is fast. Ongoing monitoring is present but not especially intensive.
4. Calibrate
Calibrate’s model is built around a 12-month commitment and leans heavily into coaching and behavior change. The program fee is separate from medication costs. It is the strongest fit for patients who already have insurance that might cover branded GLP-1s and who want a dedicated team helping push through prior authorizations. The coaching structure is more involved than most competitors here.
5. Form Health
Expensive. Worth it for the right person. Form Health pairs a physician with a registered dietitian on each case, and the ongoing monitoring is genuinely high-touch. Plan on around $299 per month before labs and medication. This is a premium-tier model that makes sense for patients who want clinical depth and have the budget or insurance coverage to support it.
6. Hims and Hers
After exiting compounded semaglutide following the March 2026 Novo Nordisk settlement, Hims and Hers shifted new patients to branded medications. Injectable Wegovy is listed at about $299 per month, oral Wegovy around $249, and Zepbound near $399. With commercial insurance and a manufacturer savings card, some patients bring that down to nearly zero. The app experience is among the smoothest in this category. Ongoing support is app-driven and relatively light clinically.
7. PlushCare
PlushCare focuses on FDA-approved branded medications only. Ozempic, Wegovy, and Mounjaro are all prescribable here, and the platform accepts insurance. The membership is about $19.99 per month, with visits, labs, and prescriptions billed separately. Same-day appointments are available. It is a straightforward option for someone who wants branded meds and insurance billing without a complicated program structure.
8. Henry Meds
Henry Meds made its name on fast turnaround. Compounded programs often ship within 24 to 72 hours of approval, and month-one pricing typically runs $179 to $249 cash. The tradeoff is that ongoing clinical monitoring is lighter than what you get from Mochi or Form Health. Good for patients who want convenience and have an outside provider handling broader health monitoring.

9. Found
Found combines coaching with medication management and charges around $99 per month for platform access, with medication billed on top. The coaching layer is more developed than a simple telehealth consult, less intensive than Calibrate’s full program. A reasonable middle-ground option for patients who want some behavioral structure without a year-long commitment.
10. Sesame (Success by Sesame)
Sesame runs a marketplace model. Annual plans start around $59 per month and include telehealth visits plus unlimited messaging. Medications are billed separately. It is among the lowest-cost entry points for ongoing access to a prescribing clinician and is worth considering for patients who are stable on a GLP-1 and mainly need routine check-ins rather than intensive monitoring.
Quick Comparison
| Provider | Model | Approx. Monthly Cost (Platform) | Compounded Option | Specialist-Level Oversight |
| FormBlends | Telehealth + 503A pharmacy | Per-vial, no membership | Yes | Physician review |
| Mochi Health | Telehealth | $99-$199 (med included) | Yes | Obesity-medicine specialists |
| Ro Body | Telehealth | $74-$149 + med | Yes (limited) | General clinician |
| Calibrate | Coaching + telehealth | Program fee + med | No | Physician + coach |
| Form Health | High-touch clinical | ~$299 + med | No | Physician + RD |
| Hims and Hers | Telehealth app | ~$249-$399 (med included) | No (post-March 2026) | General clinician |
| PlushCare | Telehealth | ~$19.99 + med | No | General clinician |
| Henry Meds | Telehealth | ~$179-$249 (med included) | Yes | General clinician |
| Found | Coaching + telehealth | ~$99 + med | Varies | General clinician |
| Sesame | Marketplace telehealth | ~$59 + med | No | General clinician |
FAQ
Is compounded semaglutide still legally available in 2026?
Yes, but the situation is narrower than it was a year ago. The FDA’s shortage list and related guidance have put pressure on compounders, and the Novo Nordisk settlement pushed several major telehealth brands to stop offering compounded versions. A 503A-licensed pharmacy can still compound semaglutide when a licensed prescriber orders it for a specific patient. The key phrase is “licensed prescriber” and “503A pharmacy,” not a bulk compounder operating without clinical oversight.
What should I actually look for in GLP-1 ongoing support?
Three things matter more than anything else: how often a real clinician reviews your case, whether dosing adjustments are handled proactively or only when you complain, and whether the provider can handle both branded and compounded options if your insurance or financial situation changes. A slick app is not a substitute for clinical follow-through.
How do I know if a compounded GLP-1 is safe?
Compounded drugs are not FDA-approved, full stop. That does not make them automatically unsafe, but it does put more of the quality burden on the pharmacy and the prescriber. Look for a 503A or 503B pharmacy, ask for batch-specific testing documentation (HPLC or mass spectrometry results), and confirm a licensed physician is actually reviewing your case rather than rubber-stamping an intake form.
Are these programs covered by insurance?
Branded medications like Wegovy, Ozempic, and Zepbound can be covered by commercial insurance or Medicare Part D depending on your plan and diagnosis. Compounded GLP-1s are almost never covered by insurance. Telehealth platform fees are generally not covered either. Some providers, including Ro and Calibrate, have staff specifically to help with prior authorizations for branded options.
What happens if I need to stop or switch medications?
This varies by provider. Higher-touch programs like Form Health and Calibrate are better equipped to manage a transition because they have dietitians and coaches in addition to prescribers. Lighter platforms may leave you working through that on your own. Before committing, ask specifically what the process looks like if you plateau, experience side effects, or need to move from compounded to branded medication.
*The information here represents independent editorial opinion based on publicly available information as of mid-2026. Before starting, adjusting, or stopping any prescription program, check in with a qualified clinician who knows your full health history.*
Sources
- FDA.gov (compounding oversight, 503A/503B guidance, GLP-1 shortage updates)
- Drugs.com (medication pricing and prescribing information)
- GoodRx (retail and insurance-adjusted drug pricing data)
- Examine.com (peptide and compound research summaries)
- Healthline (GLP-1 drug comparisons and telehealth reviews)
- Verywell Health (obesity treatment and GLP-1 clinical overviews)
- Cleveland Clinic (obesity medicine and GLP-1 mechanism resources)
- NEJM (semaglutide and tirzepatide clinical trial publications)
[internal: placement #1 | structure: Ranked listicle, comparison table, FAQ]








